Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

Summary

The purpose of this study is to assess the effect of vedolizumab intravenous IV as induction and maintenance treatment in Chinese participants with moderately to severely active ulcerative colitis (UC).

Timeline

Start

2017-08-03

Primary completion

2027-09-24

Completion

2028-01-30

Drugs

Indications